|Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy|
MS Maron, I Olivotto, S Betocchi, SA Casey, JR Lesser, MA Losi, F Cecchi, ...
New England Journal of Medicine 348 (4), 295-303, 2003
|Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction|
S Grifoni, I Olivotto, P Cecchini, F Pieralli, A Camaiti, G Santoro, A Conti, ...
Circulation 101 (24), 2817-2822, 2000
|Epidemiology of hypertrophic cardiomyopathy–related death: revisited in a large non–referral-based patient population|
BJ Maron, I Olivotto, P Spirito, SA Casey, P Bellone, TE Gohman, ...
Circulation 102 (8), 858-864, 2000
|Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction|
MS Maron, I Olivotto, AG Zenovich, MS Link, NG Pandian, JT Kuvin, ...
Circulation 114 (21), 2232-2239, 2006
|Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy|
I Olivotto, F Cecchi, SA Casey, A Dolara, JH Traverse, BJ Maron
Circulation 104 (21), 2517-2524, 2001
|Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy|
F Cecchi, I Olivotto, R Gistri, R Lorenzoni, G Chiriatti, PG Camici
New England Journal of Medicine 349 (11), 1027-1035, 2003
|Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy|
SR Ommen, BJ Maron, I Olivotto, MS Maron, F Cecchi, S Betocchi, ...
Journal of the American College of Cardiology 46 (3), 470-476, 2005
|Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy|
RH Chan, BJ Maron, I Olivotto, MJ Pencina, GE Assenza, T Haas, ...
Circulation 130 (6), 484-495, 2014
|Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine|
BJ Maron, SR Ommen, C Semsarian, P Spirito, I Olivotto, MS Maron
Journal of the American College of Cardiology 64 (1), 83-99, 2014
|Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance|
MS Maron, BJ Maron, C Harrigan, J Buros, CM Gibson, I Olivotto, L Biller, ...
Journal of the American College of Cardiology 54 (3), 220-228, 2009
|Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy|
BJ Maron, I Olivotto, P Bellone, MR Conte, F Cecchi, BP Flygenring, ...
Journal of the American College of Cardiology 39 (2), 301-307, 2002
|Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy|
I Olivotto, F Girolami, MJ Ackerman, S Nistri, JM Bos, E Zachara, ...
Mayo Clinic Proceedings 83 (6), 630-638, 2008
|Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population|
F Cecchi, I Olivotto, A Montereggi, G Santoro, A Dolara, BJ Maron
Journal of the American College of Cardiology 26 (6), 1529-1536, 1995
|Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy|
I Olivotto, MS Maron, AS Adabag, SA Casey, D Vargiu, MS Link, ...
Journal of the American College of Cardiology 46 (3), 480-487, 2005
|Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy|
MS Maron, I Olivotto, C Harrigan, E Appelbaum, CM Gibson, JR Lesser, ...
Circulation 124 (1), 40-47, 2011
|Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy|
R Coppini, C Ferrantini, L Yao, P Fan, M Del Lungo, F Stillitano, L Sartiani, ...
Circulation 127 (5), 575-584, 2013
|Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations|
F Girolami, CY Ho, C Semsarian, M Baldi, ML Will, K Baldini, F Torricelli, ...
Journal of the American College of Cardiology 55 (14), 1444-1453, 2010
|The case for myocardial ischemia in hypertrophic cardiomyopathy|
MS Maron, I Olivotto, BJ Maron, SK Prasad, F Cecchi, JE Udelson, ...
Journal of the American College of Cardiology 54 (9), 866-875, 2009
|Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study|
DA Hughes, K Nicholls, SP Shankar, G Sunder-Plassmann, D Koeller, ...
Journal of medical genetics 54 (4), 288-296, 2017
|Prognostic value of systemic blood pressure response during exercise in a community-based patient population with hypertrophic cardiomyopathy|
I Olivotto, BJ Maron, A Montereggi, F Mazzuoli, A Dolara, F Cecchi
Journal of the American College of Cardiology 33 (7), 2044-2051, 1999